| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Alzheon | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $268.07M | Series F | 8/26/2026 | $78.8M | $1.34B | $62.71 | Undisclosed Investors | ||||
 | Bellabeat | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.26M | Series C | 9/22/2022 | $21.57M | $1.01B | $35.95 | Frontierspace Ventures | ||||
 | Essence Healthcare | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $473.31M | Series 5-A2 | 4/2/2024 | $50M | $1.36B | $2.31 | Undisclosed Investors | ||||
 | Everly Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $674.09M | Series F | 12/27/2021 | $154.68M | $3.5B | $64.45 | Touchdown Ventures, Prysm Capital | ||||
 | Imperative Care | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $898.94M | Series E-3 | 7/25/2024 | $25M | $1.66B | $6.87 | Ally Bridge Group, D1 Capital Partners, AMED Ventures, Bain Capital Life Sciences, Rock Springs Capital, Innovatus Capital Partners, Pura Vida Investments, Catalio Capital Management, HealthCor, Montreux Growth Partners, INTAI Technology | ||||
 | Insitro | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.26B | Series C | 3/15/2021 | $400M | $2.57B | $18.29 | CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank | ||||
 | Tebra | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $136.50K | -- | 1 | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Evidation Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $365.04M | Series E-2 | 9/23/2024 | $105M | $1.11B | $18.51 | Undisclosed Investors | ||||
 | Biosplice Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Medable | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $530.96M | Series D | 10/26/2021 | $304.88M | $2.1B | $9.67 | Blackstone Growth, Tiger Global, GSR Ventures, Sapphire Ventures, WTI | ||||
 | Modern Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $170.58M | Series D | 2/11/2021 | $74M | $1.17B | $44.05 | Founders Fund, Lachy Groom | ||||
 | Talkiatry | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $301.92M | Series D | 2/12/2026 | $115M | $1.35B | $0.59 | Perceptive Advisors, Sofina, Andreessen Horowitz, blisce, Left Lane Capital | ||||
 | Iterative Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $272.32M | Series C | 4/30/2026 | $77.01M | $1.3B | $26.32 | Intrepid Growth Partners, GV, EDBI, Insight Partners, Obvious Ventures | ||||
 | PathAI | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $255.49M | Series C | 5/19/2021 | $165M | $1.11B | $29.50 | D1 Capital Partners, Kaiser Permanente, General Atlantic, Tiger Global Management, 8VC, Adage, Biospring Partners, General Catalyst, KdT Ventures, Polaris Partners, Refactor Capital, Bristol-Myers Squibb Company, Labcorp, Merck Global Health Innovation Fund | ||||
 | Treeline Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.1B | Series A-2 | 9/3/2025 | $200.1M | $1.83B | $8.61 | Access Industries, ARCH Venture Partners, OrbiMed, GV, KKR, T. Rowe Price Associates, Ajax Health, Casdin Capital, Fidelity, Aisling Capital, Rock Springs Capital, Exor | ||||
 | Assort Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $220.77M | Series C | 6/24/2026 | $110.32M | $1.2B | $47.65 | Menlo Ventures, Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, Quiet Capital | ||||
 | Astromech | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $60.5M | Series Seed-2 | 8/20/2026 | $20M | $3.8B | $29.06 | Robert Nelsen, Peak 6, NeoGenesis Capital, Builders VC, CAZ Investments | ||||
 | Caresyntax | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $943.58M | Series D-1 | 9/15/2025 | $688.92M | $1.27B | $172.23 | Undisclosed Investors | ||||
 | Grow Therapy | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $169.84K | -- | 1 | Not available | -- | -- | $152.29M | Series C | 4/8/2024 | $88M | $1.42B | $8.70 | Sequoia Capital, Goldman Sachs, PLUS Capital, Anna Kendrick, Lily Collins, Dak Prescott, Joe Burrow, Jrue Holiday, Lauren Holiday, Transformation Capital, SignalFire, TCV | ||||
 | Immunai | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $295.22M | Series C-1 | 10/27/2021 | $204.34M | $1.15B | $186.65 | Koch Disruptive Technologies, Talos VC, 8VC, Alexanria Venture Investments, Piedmont, ICON | ||||
 | Incredible Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $97.08M | Series B | 8/17/2022 | $80M | $1.65B | $85.10 | Base10 Partners, Obvious Ventures, Workday, Andre Iguodala, Chano Fernandez, 444 Capital Fund, Andreessen Horowitz, Kaiser Permanante | ||||
 | Nomi Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $192.04M | Series B | 6/29/2023 | $118.25M | $1.71B | $68.85 | Undisclosed Investors | ||||
 | Parallel | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $228.07M | Series D | 6/27/2019 | $130.89M | $2.47B | $43.63 | Ed Brown | ||||
 | SonderMind | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $189.93M | Series C | 7/28/2021 | $150M | $1.56B | $18.03 | Drive Capital, Premji Invest, General Catalyst, Partners Group, Smash Ventures, Kickstart Fund, F-Prime Capital | ||||